Almudena
Amor Salamanca
Ikertzailea 2013-2021 tartean
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers
Journal of Medical Genetics, Vol. 61, Núm. 5, pp. 423-427